Clinical Trial Results:
Prospective randomised phase II trial of oral vinorelbine and cisplatin or pemetrexed and cisplatin in first line Metastatic or Locally Advanced Non-Small-Cell Lung Cancer patients with non-squamous histological type.
Summary
|
|
EudraCT number |
2009-012001-19 |
Trial protocol |
FR DE PT AT IT ES CZ |
Global completion date |
09 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2016
|
First version publication date |
13 Feb 2016
|
Other versions |
|
Summary report(s) |
2009-012001-19- Phase 2 Oral Vinorelbine in Non Small Cell Lung Cancer - NAVotrial01 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.